204 related articles for article (PubMed ID: 11245656)
1. Recombinant hirudin in clinical practice: focus on lepirudin.
Greinacher A; Lubenow N
Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
[TBL] [Abstract][Full Text] [Related]
2. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
3. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
5. Lepirudin for heparin-induced thrombocytopenia.
Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
[No Abstract] [Full Text] [Related]
6. Lepirudin anticoagulation for heparin-induced thrombocytopenia.
Deitcher SR; Topoulos AP; Bartholomew JR; Kichuk-Chrisant MR
J Pediatr; 2002 Feb; 140(2):264-6. PubMed ID: 11865285
[TBL] [Abstract][Full Text] [Related]
7. Lepirudin in the management of heparin-induced thrombocytopenia.
Gajra A; Husain J; Smith A
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
[TBL] [Abstract][Full Text] [Related]
8. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulants in acute coronary syndromes.
Turpie AG
Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
[TBL] [Abstract][Full Text] [Related]
10. Image of the month. Heparin-induced thrombocytopenia: stop all heparin therapy and treat with lepirudin.
Bush RL; Lin PH; Lumsden AB
Arch Surg; 2002 Feb; 137(2):221-2. PubMed ID: 11822964
[No Abstract] [Full Text] [Related]
11. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
12. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
13. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M
Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094
[TBL] [Abstract][Full Text] [Related]
14. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
16. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
Greinacher A
Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
[TBL] [Abstract][Full Text] [Related]
17. [Treatment with lepirudin in heparin-induced thrombocytopenia. A case report].
Nippert M; de Maistre E; Rodermann M; Vançon AC; Amrein D; Brembilla-Perrot B; Lecompte T; Zannad F; Aliot E
Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1234-8. PubMed ID: 12611047
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
19. Therapy for patients with heparin-induced thrombocytopenia marketed.
Am J Health Syst Pharm; 1998 Jul; 55(14):1444. PubMed ID: 9676284
[No Abstract] [Full Text] [Related]
20. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]